Future development of pentostatin (Nipent): Opportunities for using a highly effective, safe agent for hematologic and autoimmune diseases

Research output: Contribution to journal › Article › peer-review

Cite this

@article{9c535d4459f34d2ba012dd5a25aa8570,

title = "Future development of pentostatin (Nipent): Opportunities for using a highly effective, safe agent for hematologic and autoimmune diseases",

author = "Byrd, \{J. C.\} and Grever, \{M. R.\}",

year = "2000",

month = jul,

day = "12",

language = "English",

volume = "27",

pages = "1--2",

journal = "Seminars in Oncology",

issn = "0093-7754",

number = "3 SUPPL. 5",

}

TY - JOUR

T1 - Future development of pentostatin (Nipent)

T2 - Opportunities for using a highly effective, safe agent for hematologic and autoimmune diseases

AU - Byrd, J. C.

AU - Grever, M. R.

PY - 2000/7/12

Y1 - 2000/7/12

UR - https://www.scopus.com/pages/publications/0033919636

M3 - Article

C2 - 10877043

AN - SCOPUS:0033919636

SN - 0093-7754

VL - 27

SP - 1

EP - 2

JO - Seminars in Oncology

JF - Seminars in Oncology

IS - 3 SUPPL. 5

ER -